Time-course changes of nLDL-induced erectile dysfunction

Area of Science:

• Cardiovascular Biology
• Urology
• Metabolic Research

Background:

• Hyperlipidemia is a significant risk factor for atherosclerosis and commonly co-occurs with erectile dysfunction (ED).
• Native low-density lipoprotein (nLDL) may acutely impact erectile function, but its long-term effects and underlying mechanisms remain unclear.

Purpose of the Study:

• To investigate the reversibility of acute nLDL-induced erectile dysfunction.
• To determine the relationship between erectile dysfunction, plasma asymmetrical dimethylarginine (ADMA), and endothelial nitric oxide synthase (eNOS) in cavernous tissues.

Main Methods:

• Hyperlipidemia was induced in rats via a single intravenous injection of nLDL.
• Erectile function (ICP/MAP ratio), endothelium-dependent relaxations, plasma ADMA, and eNOS expression (mRNA and protein) were assessed at 72 hours, 2 weeks, and 8 weeks post-injection.

Main Results:

• The ICP/MAP ratio significantly decreased at 2 and 8 weeks, indicating impaired erectile function.
• Endothelium-dependent relaxations were compromised at 8 weeks, accompanied by elevated plasma ADMA levels.
• eNOS mRNA expression decreased over time, while eNOS protein levels increased, suggesting complex regulatory changes.

Conclusions:

• Acute nLDL-induced erectile dysfunction is largely irreversible over an 8-week period.
• The observed dysfunction is potentially linked to elevated ADMA levels and dysregulation of the eNOS/NO pathway.